These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28816235)

  • 1. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
    Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT
    Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
    PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-κB activation by demethylating R149 of the p65 subunit.
    Guo Z; Hu YH; Feng GS; Valenzuela Ripoll C; Li ZZ; Cai SD; Wang QQ; Luo WW; Li Q; Liang LY; Wu ZK; Zhang JG; Javaheri A; Wang L; Lu J; Liu PQ
    Acta Pharmacol Sin; 2023 Sep; 44(9):1777-1789. PubMed ID: 37186122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of IκBα in cardiomyocytes alleviates hydrogen peroxide-induced apoptosis and autophagy by inhibiting NF-κB activation.
    Han M; Chen XC; Sun MH; Gai MT; Yang YN; Gao XM; Ma X; Chen BD; Ma YT
    Lipids Health Dis; 2020 Jun; 19(1):150. PubMed ID: 32580730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
    Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway.
    Gao H; Liu H; Tang T; Huang X; Wang D; Li Y; Huang P; Peng Y
    Mol Cell Endocrinol; 2018 Jul; 470():259-268. PubMed ID: 29138023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: roles of the NF-κB and MAPK signaling pathways.
    Abdelhamid G; El-Kadi AO
    Free Radic Biol Med; 2015 May; 82():1-12. PubMed ID: 25614461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorogenic acid prevents isoproterenol-induced hypertrophy in neonatal rat myocytes.
    Li Y; Shen D; Tang X; Li X; Wo D; Yan H; Song R; Feng J; Li P; Zhang J; Li J
    Toxicol Lett; 2014 May; 226(3):257-63. PubMed ID: 24583048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
    Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
    Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.
    Yu SS; Cai Y; Ye JT; Pi RB; Chen SR; Liu PQ; Shen XY; Ji Y
    Br J Pharmacol; 2013 Jan; 168(1):117-28. PubMed ID: 22335191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats.
    Gupta S; Young D; Sen S
    Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H20-9. PubMed ID: 15749748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
    Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
    Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT6 suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy.
    Lu J; Sun D; Liu Z; Li M; Hong H; Liu C; Gao S; Li H; Cai Y; Chen S; Li Z; Ye J; Liu P
    Transl Res; 2016 Jun; 172():96-112.e6. PubMed ID: 27016702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NF-κB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress.
    Yu XJ; Zhang DM; Jia LL; Qi J; Song XA; Tan H; Cui W; Chen W; Zhu GQ; Qin DN; Kang YM
    Toxicol Appl Pharmacol; 2015 May; 284(3):315-22. PubMed ID: 25759242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
    Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MG53, A Novel Regulator of KChIP2 and I
    Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J
    Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-κB and JAK/STAT signaling pathways in rats.
    Zhao L; Wu D; Sang M; Xu Y; Liu Z; Wu Q
    Int Immunopharmacol; 2017 Jul; 48():102-109. PubMed ID: 28499193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
    Chen J; Chen Y; Zhu W; Han Y; Han B; Xu R; Deng L; Cai Y; Cong X; Yang Y; Hu S; Chen X
    J Cell Biochem; 2008 Apr; 103(6):1718-31. PubMed ID: 17891781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling.
    Wang PX; Li ZM; Cai SD; Li JY; He P; Huang Y; Feng GS; Luo HB; Chen SR; Liu PQ
    Acta Pharmacol Sin; 2017 Sep; 38(9):1257-1268. PubMed ID: 28649129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.